As on April 07, 2021, Idera Pharmaceuticals Inc. (NASDAQ: IDRA) got off with the flyer as it spiked 6.11% to $1.39. During the day, the stock rose to $1.59 and sunk to $1.28 before settling in for the price of $1.31 at the close. Taking a more long-term approach, IDRA posted a 52-week range of $1.22-$6.14.
Meanwhile, its Annual Earning per share during the time was 0.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -12.50%. This publicly-traded company’s shares outstanding now amounts to $36.29 million, simultaneously with a float of $25.52 million. The organization now has a market capitalization sitting at $57.81 million. At the time of writing, stock’s 50-day Moving Average stood at $4.0714, while the 200-day Moving Average is $3.1865.
Idera Pharmaceuticals Inc. (IDRA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Idera Pharmaceuticals Inc.’s current insider ownership accounts for 1.40%, in contrast to 22.60% institutional ownership. According to the most recent insider trade that took place on Mar 25, this organization’s CHIEF MEDICAL OFFICER sold 5,018 shares at the rate of 1.35, making the entire transaction reach 6,778 in total value, affecting insider ownership by 13,237. Preceding that transaction, on Mar 25, Company’s SVP AND GENERAL COUNSEL sold 7,630 for 1.36, making the whole transaction’s value amount to 10,378. This particular insider is now the holder of 30,434 in total.
Idera Pharmaceuticals Inc. (IDRA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2020, the company posted -$2.11 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.23) by -$1.88. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
Idera Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -12.50% and is forecasted to reach -0.60 in the upcoming year.
Idera Pharmaceuticals Inc. (NASDAQ: IDRA) Trading Performance Indicators
Let’s observe the current performance indicators for Idera Pharmaceuticals Inc. (IDRA). It’s Quick Ratio in the last reported quarter now stands at 5.90. The Stock has managed to achieve an average true range (ATR) of 0.40.
In the same vein, IDRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.15, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -0.60 at the market close of one year from today.
Technical Analysis of Idera Pharmaceuticals Inc. (IDRA)
Through scrutinizing the latest numbers posted by the [Idera Pharmaceuticals Inc., IDRA], it can be observed that its last 5-days Average volume of 5.72 million was better the volume of 2.62 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 34.02% While, its Average True Range was 0.3173.
Raw Stochastic average of Idera Pharmaceuticals Inc. (IDRA) in the period of the previous 100 days is set at 3.46%, which indicates a major fall in contrast to 3.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 392.63% that was higher than 187.78% volatility it exhibited in the past 100-days period.